Preclinical CRO Market Size, Share & COVID-19 Impact Analysis, By Type (Drug Metabolism and Pharmacokinetics (DMPK), Bioanalysis, Toxicology Studies, and Safety Services), By Application (Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorders, and Others), By End-user (Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI106939

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2017-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2017-2021
Growth Rate	CAGR of 13.9% from 2023-2030
Unit	Value (USD billion)
Segmentation	By Type Drug Metabolism and Pharmacokinetics (DMPK) Bioanalysis Toxicology Studies Safety services
	By Application Oncology Neurology Cardiology Infectious Diseases Metabolic Disorders Others
	By End-user Pharmaceutical & Biotechnological Companies Academic & Research Institutes Others
	By Region North America (By Type, By Application, By End-user, and By Country) U.S. Canada Europe (By Type, By Application, By End-user, and By Country/Sub-region) U.K. Germany France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Type, By Application, By End-user, and By Country/Sub-region) Japan China Australia India Southeast Asia Rest of Asia Pacific Rest of the World (By Type, By Application, and By End-user)